Ontology highlight
ABSTRACT:
Objectives: To describe a series of patients with familial macrothrombocytopenia and decreased expression of ?IIb?3 integrin due to defects in the ITGA2B or ITGB3 genes.
Methods: We reviewed the clinical and laboratory records of 10 Portuguese families with GTLS (33 patients and 11 unaffected relatives), including the functional and genetic defects.
Results: Patients had absent to moderate bleeding, macrothrombocytopenia, low ?IIb?3 expression, impaired platelet aggregation/ATP release to physiological agonists and low expression of activation-induced binding sites on ?IIb?3 (PAC-1) and receptor-induced binding sites on its ligand (bound fibrinogen), upon stimulation with TRAP-6 and ADP. Evidence for constitutive ?IIb?3 activation, occurred in 2 out of 9 patients from 8 families studied, but also in 2 out of 12 healthy controls. We identified 7 missense variants: 3 in ITGA2B (5 families), and 4 in ITGB3 (5 families). Three variants (?IIb: p.Arg1026Trp and p.Arg1026Gln and ?3: p.Asp749His) were previously reported. The remaining (?IIb: p.Gly1007Val and ?3: p.Thr746Pro, p.His748Pro and p.Arg760Cys) are new, expanding the ?IIb?3 defects associated with GTLS. The integration of the clinical and laboratory data allowed the identification of two GTLS subgroups, with distinct disease severity.
Conclusions: Previously reported ITGA2B and ITGB3 variants related to thrombocytopenia were clustered in a confined region of the membrane-proximal cytoplasmic domains, the inner membrane clasp. For the first time, variants are reported at the outer membrane clasp, at the transmembrane domain of ?IIb, and at the membrane distal cytoplasmic domains of ?3. This is the largest single-center series of inherited macrothrombocytopenia associated with ?IIb?3 variants published to date.
SUBMITTER: Morais S
PROVIDER: S-EPMC7717987 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
PloS one 20201204 12
<h4>Background</h4>Rare pathogenic variants in either the ITGA2B or ITGB3 genes have been linked to autosomal dominant macrothrombocytopenia associated with abnormal platelet production and function, deserving the designation of Glanzmann Thrombasthenia-Like Syndrome (GTLS) or ITGA2B/ITGB3-related thrombocytopenia.<h4>Objectives</h4>To describe a series of patients with familial macrothrombocytopenia and decreased expression of αIIbβ3 integrin due to defects in the ITGA2B or ITGB3 genes.<h4>Meth ...[more]